These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 21508394

  • 1. Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer.
    Pylväs M, Puistola U, Laatio L, Kauppila S, Karihtala P.
    Anticancer Res; 2011 Apr; 31(4):1411-5. PubMed ID: 21508394
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
    Chung HH, Kwon HW, Kang KW, Park NH, Song YS, Chung JK, Kang SB, Kim JW.
    Ann Surg Oncol; 2012 Jun; 19(6):1966-72. PubMed ID: 22124757
    [Abstract] [Full Text] [Related]

  • 3. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer.
    Asher V, Lee J, Innamaa A, Bali A.
    Clin Transl Oncol; 2011 Jul; 13(7):499-503. PubMed ID: 21775277
    [Abstract] [Full Text] [Related]

  • 4. Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer.
    Mury D, Woelber L, Jung S, Eulenburg C, Choschzick M, Witzel I, Schwarz J, Jaenicke F, Mahner S.
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1131-7. PubMed ID: 21344262
    [Abstract] [Full Text] [Related]

  • 5. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.
    Healy DL, Burger HG, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Day AJ, Rome R, Campbell JJ.
    N Engl J Med; 1993 Nov 18; 329(21):1539-42. PubMed ID: 8413476
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study.
    Lea J, Sharma R, Yang F, Zhu H, Ward ES, Schroit AJ.
    Oncotarget; 2017 Feb 28; 8(9):14395-14407. PubMed ID: 28122335
    [Abstract] [Full Text] [Related]

  • 8. LyGDI is a promising biomarker for ovarian cancer.
    Zhen H, Yang S, Wu H, Wang S, Lv J, Ma L, Zhang X.
    Int J Gynecol Cancer; 2010 Apr 28; 20(3):316-22. PubMed ID: 20375790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.
    Moolthiya W, Yuenyao P.
    Asian Pac J Cancer Prev; 2009 Apr 28; 10(5):865-8. PubMed ID: 20162854
    [Abstract] [Full Text] [Related]

  • 13. Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.
    Fotopoulou C, Zang R, Gultekin M, Cibula D, Ayhan A, Liu D, Richter R, Braicu I, Mahner S, Harter P, Trillsch F, Kumar S, Peiretti M, Dowdy SC, Maggioni A, Trope C, Sehouli J.
    Ann Surg Oncol; 2013 Apr 28; 20(4):1348-54. PubMed ID: 23054114
    [Abstract] [Full Text] [Related]

  • 14. Prognostic impact of additional extended surgical procedures in advanced-stage primary ovarian cancer.
    Kommoss S, Rochon J, Harter P, Heitz F, Grabowski JP, Ewald-Riegler N, Haberstroh M, Neunhoeffer T, Barinoff J, Gomez R, Traut A, du Bois A.
    Ann Surg Oncol; 2010 Jan 28; 17(1):279-86. PubMed ID: 19898901
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.
    Simmons AR, Fourkala EO, Gentry-Maharaj A, Ryan A, Sutton MN, Baggerly K, Zheng H, Lu KH, Jacobs I, Skates S, Menon U, Bast RC.
    Cancer Prev Res (Phila); 2019 Jun 28; 12(6):391-400. PubMed ID: 30967390
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
    Wang MJ, Qi J, Wang H, Li XX, Wei BJ, Fu C, Gao J, Han BB.
    Zhonghua Zhong Liu Za Zhi; 2011 Jul 28; 33(7):540-3. PubMed ID: 22093635
    [Abstract] [Full Text] [Related]

  • 20. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
    Carbotti G, Orengo AM, Mezzanzanica D, Bagnoli M, Brizzolara A, Emionite L, Puppo A, Centurioni MG, Bruzzone M, Marroni P, Rossello A, Canevari S, Ferrini S, Fabbi M.
    Int J Cancer; 2013 Jun 01; 132(11):2597-605. PubMed ID: 23169448
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.